NCT04252768 2023-03-22
AIPAC-002
Immutep S.A.S.
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT02676869 2019-12-18
TACTI-mel
Immutep Australia Pty. Ltd.
Phase 1 Completed
NCT00349934 2010-01-07
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Immutep S.A.S.
Phase 1 Completed
NCT00351949 2010-01-07
IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)
Immutep S.A.S.
Phase 1 Completed